{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T17:25:06Z","timestamp":1772645106466,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,13]]},"DOI":"10.7759\/cureus.38975","type":"journal-article","created":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T19:16:05Z","timestamp":1684005365000},"source":"Crossref","is-referenced-by-count":3,"title":["Myelin Oligodendrocyte Glycoprotein Optic Neuritis Presenting With Orbital Apex Syndrome"],"prefix":"10.7759","author":[{"given":"Farhana Nabila","family":"Sulaiman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nur Farhana","family":"Kamardin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Iliyas","family":"Sultan Abdul Kader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannie","family":"Ch'ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan Haslina","family":"Wan Abdul Halim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/01.icu.0000144387.12739.9c","article-title":"Orbital apex syndrome","volume":"15","author":"Yeh S","year":"2004","unstructured":"Yeh S, Foroozan R. Orbital apex syndrome. Curr Opin Ophthalmol. 2004, 15:490-8. 10.1097\/01.icu.0000144387.12739.9c","journal-title":"Curr Opin Ophthalmol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2022.104168","article-title":"The prevalence, demographics, clinical features, neuroimaging, and inter-ethnic differences of MOGAD in Malaysia with global perspectives","volume":"67","author":"Ong ZM","year":"2022","unstructured":"Ong ZM, Arip M, Ching YM, et al.. The prevalence, demographics, clinical features, neuroimaging, and inter-ethnic differences of MOGAD in Malaysia with global perspectives. Mult Scler Relat Disord. 2022, 67:104168. 10.1016\/j.msard.2022.104168","journal-title":"Mult Scler Relat Disord"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(22)00200-9","article-title":"Diagnosis and classification of optic neuritis","volume":"21","author":"Petzold A","year":"2022","unstructured":"Petzold A, Fraser CL, Abegg M, et al.. Diagnosis and classification of optic neuritis. Lancet Neurol. 2022, 21:1120-34. 10.1016\/S1474-4422(22)00200-9","journal-title":"Lancet Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-018-9122-2","article-title":"Neurological update: MOG antibody\u00a0disease","volume":"266","author":"Wynford-Thomas R","year":"2019","unstructured":"Wynford-Thomas R, Jacob A, Tomassini V. Neurological update: MOG antibody\u00a0disease. J Neurol. 2019, 266:1280-6. 10.1007\/s00415-018-9122-2","journal-title":"J Neurol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2018.07.020","article-title":"Myelin oligodendrocyte glycoprotein antibody-positive optic neuritis: clinical characteristics, radiologic clues, and outcome","volume":"195","author":"Chen JJ","year":"2018","unstructured":"Chen JJ, Flanagan EP, Jitprapaikulsan J, et al.. Myelin oligodendrocyte glycoprotein antibody-positive optic neuritis: clinical characteristics, radiologic clues, and outcome. Am J Ophthalmol. 2018, 195:8-15. 10.1016\/j.ajo.2018.07.020","journal-title":"Am J Ophthalmol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines7020042","article-title":"Neuromyelitis optica spectrum disorder and anti-MOG syndromes","volume":"7","author":"Lana-Peixoto MA","year":"2019","unstructured":"Lana-Peixoto MA, Talim N. Neuromyelitis optica spectrum disorder and anti-MOG syndromes. Biomedicines. 2019, 7:42. 10.3390\/biomedicines7020042","journal-title":"Biomedicines"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(22)00187-9","article-title":"Optic neuritis and autoimmune optic neuropathies: advances in diagnosis and treatment","volume":"22","author":"Bennett JL","year":"2023","unstructured":"Bennett JL, Costello F, Chen JJ, Petzold A, Biousse V, Newman NJ, Galetta SL. Optic neuritis and autoimmune optic neuropathies: advances in diagnosis and treatment. Lancet Neurol. 2023, 22:89-100. 10.1016\/S1474-4422(22)00187-9","journal-title":"Lancet Neurol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.14452","article-title":"Myelin oligodendrocyte glycoprotein (MOG) optic neuritis: a case series","volume":"13","author":"Nurul-Ain M","year":"2021","unstructured":"Nurul-Ain M, Khairul Kamal ZN, Wan Hitam WH, Abd Munaaim M, Mohd Zaki F. Myelin oligodendrocyte glycoprotein (MOG) optic neuritis: a case series. Cureus. 2021, 13:e14452. 10.7759\/cureus.14452","journal-title":"Cureus"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/01658107.2021.1964541","article-title":"Update on optic neuritis: an international view","volume":"46","author":"Hickman SJ","year":"2022","unstructured":"Hickman SJ, Petzold A. Update on optic neuritis: an international view. Neuroophthalmology. 2022, 46:1-18. 10.1080\/01658107.2021.1964541","journal-title":"Neuroophthalmology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2014.108","article-title":"The investigation of acute optic neuritis: a review and proposed protocol","volume":"10","author":"Petzold A","year":"2014","unstructured":"Petzold A, Wattjes MP, Costello F, et al.. The investigation of acute optic neuritis: a review and proposed protocol. Nat Rev Neurol. 2014, 10:447-58. 10.1038\/nrneurol.2014.108","journal-title":"Nat Rev Neurol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2020-317267","article-title":"Ophthalmic manifestations of myelin oligodendrocyte glycoprotein-IgG-associated disorder other than optic neuritis: a systematic review","volume":"105","author":"Vosoughi AR","year":"2021","unstructured":"Vosoughi AR, Ling J, Tam KT, Blackwood J, Micieli JA. Ophthalmic manifestations of myelin oligodendrocyte glycoprotein-IgG-associated disorder other than optic neuritis: a systematic review. Br J Ophthalmol. 2021, 105:1591-8. 10.1136\/bjophthalmol-2020-317267","journal-title":"Br J Ophthalmol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000503","article-title":"MOG antibodies in combined central and peripheral demyelination syndromes","volume":"5","author":"Vazquez Do Campo R","year":"2018","unstructured":"Vazquez Do Campo R, Stephens A, Marin Collazo IV, Rubin DI. MOG antibodies in combined central and peripheral demyelination syndromes. Neurol Neuroimmunol Neuroinflamm. 2018, 5:e503. 10.1212\/NXI.0000000000000503","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1080\/01658107.2019.1571089","article-title":"Case report: anti-myelin oligodendrocyte glycoprotein (MOG) positive in a patient presented with orbital apex syndrome","volume":"44","author":"Kurathong S","year":"2019","unstructured":"Kurathong S, Sanpatchayapong A, Apiwattanakul M. Case report: anti-myelin oligodendrocyte glycoprotein (MOG) positive in a patient presented with orbital apex syndrome. Neuroophthalmology. 2019, 44:255-7. 10.1080\/01658107.2019.1571089","journal-title":"Neuroophthalmology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/1352458515614093","article-title":"The clinical spectrum associated with myelin oligodendrocyte glycoprotein antibodies (anti-MOG-Ab) in Thai patients","volume":"22","author":"Siritho S","year":"2016","unstructured":"Siritho S, Sato DK, Kaneko K, Fujihara K, Prayoonwiwat N. The clinical spectrum associated with myelin oligodendrocyte glycoprotein antibodies (anti-MOG-Ab) in Thai patients. Mult Scler. 2016, 22:964-8. 10.1177\/1352458515614093","journal-title":"Mult Scler"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1144-2","article-title":"MOG encephalomyelitis: international recommendations on diagnosis and antibody testing","volume":"15","author":"Jarius S","year":"2018","unstructured":"Jarius S, Paul F, Aktas O, et al.. MOG encephalomyelitis: international recommendations on diagnosis and antibody testing. J Neuroinflammation. 2018, 15:134. 10.1186\/s12974-018-1144-2","journal-title":"J Neuroinflammation"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-019-0541-x","article-title":"Treatment approaches for MOG-Ab-associated demyelination in children","volume":"21","author":"Hacohen Y","year":"2019","unstructured":"Hacohen Y, Banwell B. Treatment approaches for MOG-Ab-associated demyelination in children. Curr Treat Options Neurol. 2019, 21:2. 10.1007\/s11940-019-0541-x","journal-title":"Curr Treat Options Neurol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/150891-myelin-oligodendrocyte-glycoprotein-optic-neuritis-presenting-with-orbital-apex-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:59:55Z","timestamp":1707508795000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/150891-myelin-oligodendrocyte-glycoprotein-optic-neuritis-presenting-with-orbital-apex-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,13]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.38975","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,13]]}}}